Daniel Moj

Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug–Drug Interactions and Co-medication Regimens

Thorsten Lehr, Sebastian Frechen, W. Haefeli, 2016, The AAPS Journal.

PBPK Models for CYP3A4 and P‐gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin

Thorsten Lehr, Sebastian Frechen, T. Lehr, 2018, CPT: pharmacometrics & systems pharmacology.